Cytokine Signalling Forum
Congress Author Podcast - ACR 2019 Upadacitinib
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:26:27
- Mas informaciones
Informações:
Sinopsis
In this edition experts, including Professor Smolen and Professor McInnes, present the latest data for the recently approved JAK inhibitor, upadacitinib. The presentations include: data from the SELECT trials, safety analyses, switching from TNF inhibitors, and the mode of action of upadacitinib.
